Primorus Investments - Resignation of Directors
RNS Number : 2005F
Primorus Investments PLC
13 November 2020


Primorus Investments PLC


("Primorus" or the "Company")


Resignation of Directors


Primorus Investments PLC (AIM: PRIM; AQSE: PRIM) announces the resignations of Alastair Clayton and Jeremy Taylor-Firth who step down with immediate effect as Executive Director and Non-Executive Chairman of the Company respectively.

Rupert Labrum will assume the role of Executive Chairman of the Company until further notice. The board of Primorus (the "Board") is currently undertaking a strategic review of the Company and its business, which shall include a review of the current Board composition. Once the strategic review is completed, a further update will be provided.

Rupert Labrum, Executive Chairman, said: "I would like to thank Alastair and Jeremy for their contributions over the past several years, not least for their part in the value creation and realisation from the recently completed divestiture of the Company's stake in Greatland Gold plc. The Board wishes them well in their future endeavours."


This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

For further information, please contact:


Primorus Investments plc:          

+44 (0) 7818 411 271 

Rupert Labrum




Nominated Adviser:

+44 (0) 20 7213 0880

Cairn Financial Advisers LLP


James Caithie / Sandy Jamieson





+44 (0) 20 3657 0050

Turner Pope Investments


Andy Thacker / Zoe Alexander



This information is provided by RNS, the news service of the . RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the use the personal data you provide us, please see our Privacy Policy.